A 24-Week Study to Evaluate the Safety and Efficacy of ADVAIR DISKUS® Inhaler 250/50mcg Plus SPIRIVA HANDIHALER® Inhaler Versus SPIRIVA HANDIHALER® Inhaler Plus Placebo DISKUS® Inhaler in Subjects With Chronic Obstructive Pulmonary Disease (COPD).

GSK Investigational Site, Albany

GSK Investigational Site, Erie

GSK Investigational Site, Richmond

GSK Investigational Site, Newport News

GSK Investigational Site, Elizabeth City

GSK Investigational Site, Mooresville

GSK Investigational Site, Statesville

GSK Investigational Site, Spartanburg

GSK Investigational Site, Gaffney

GSK Investigational Site, Union

GSK Investigational Site, Greenville

GSK Investigational Site, DeLand

GSK Investigational Site, Naranja

GSK Investigational Site, Clearwater

GSK Investigational Site, Milan

GSK Investigational Site, Louisville

GSK Investigational Site, Cleveland

GSK Investigational Site, Cincinnati

GSK Investigational Site, Elkhart

GSK Investigational Site, Gillespie

GSK Investigational Site, Saint Charles

GSK Investigational Site, Olathe

GSK Investigational Site, Omaha

GSK Investigational Site, Sunset

GSK Investigational Site, Shreveport

GSK Investigational Site, Plano

GSK Investigational Site, Houston

GSK Investigational Site, Houston

GSK Investigational Site, Boerne

GSK Investigational Site, Fort Collins

GSK Investigational Site, Coeur d'Alene

GSK Investigational Site, West Jordan

GSK Investigational Site, Riverside

GSK Investigational Site, Cumberland

GSK Investigational Site, Charleston